TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 45 filers reported holding TRINITY BIOTECH PLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $5,000 | 0.0% | 900 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | 0.0% | 900 | 0.0% | 0.00% | – |
| Q4 2017 | $5,000 | 0.0% | 900 | 0.0% | 0.00% | – |
| Q3 2017 | $5,000 | 0.0% | 900 | 0.0% | 0.00% | – |
| Q2 2017 | $5,000 | 0.0% | 900 | 0.0% | 0.00% | – |
| Q1 2017 | $5,000 | -28.6% | 900 | -12.3% | 0.00% | – |
| Q4 2016 | $7,000 | -89.6% | 1,026 | -79.6% | 0.00% | -100.0% |
| Q3 2016 | $67,000 | +42.6% | 5,028 | +19.9% | 0.00% | +100.0% |
| Q2 2016 | $47,000 | – | 4,195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
| GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
| Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
| Centaur Capital | 77,500 | $887,000 | 1.33% |
| Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
| Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
| RK Capital | 565,472 | $6,469,000 | 1.18% |
| Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
| Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
| KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |